National Cholesterol Education Program
Top
National Heart, Lung, and
Blood Institute
National Cholesterol Education Program
Source: No longer available on the web except
here
Reference: Major Article by Karl Loren About
Cholesterol
Reference: Major Article by Karl Loren About
"Plaque'
The National Heart, Lung, and Blood Institute (NHLBI) launched the National
Cholesterol Education Program (NCEP) in November 1985. The goal of the NCEP is
to contribute to reducing illness and death from coronary heart disease (CHD) in
the United States by reducing the percent of Americans with high blood
cholesterol. Through educational efforts directed at health professionals and
the public, the NCEP aims to raise awareness and understanding about high blood
cholesterol as a risk factor for CHD and the benefits of lowering cholesterol
levels as a means of preventing CHD.
- Program Description
- Coordinating Committee
[Meeting
Notes] [Roster]
- Health Related Information
[Patients/General
Public] [HealthCare/Other
Professionals]
- Cholesterol Education Month Kit
National Cholesterol Education Program
PROGRAM DESCRIPTION
The National Heart, Lung, and Blood Institute (NHLBI) of the National
Institutes of Health (NIH) launched the National Cholesterol Education Program
(NCEP) in November 1985. The goal of the NCEP is to contribute to reducing
illness and death from coronary heart disease in the United States by reducing
the percentage of Americans with high blood cholesterol. Through educational
efforts directed at health professionals and the public, the NCEP aims to raise
awareness and understanding about high blood cholesterol as a risk factor for
coronary heart disease and the benefits of lowering cholesterol levels as a
means of preventing coronary heart disease.
The NCEP is one of the cardiovascular risk factor education programs
administered by the Office of Prevention, Education, and Control at NHLBI.
Others are the National High Blood Pressure Education Program and the NHLBI
Obesity Education Initiative. Elevated blood cholesterol, high blood pressure,
and obesity as well as smoking are important modifiable risk factors for
cardiovascular disease.
A Decade of Progress
In its 10 years of existence, the NCEP has made
significant strides toward its goal of reducing the prevalence of high blood
cholesterol in the United States. Evidence of this progress is clearly visible
in the latest Cholesterol Awareness Survey (CAS) of physicians and the public,
whose results were released at the 10th anniversary of the NCEP. From 1983 to
1995, the percentage of the public who ever had their blood cholesterol checked
rose from 35 to 75 percent. This means that some 70 to 80 million Americans who
in 1983 were unaware of their blood cholesterol level have now taken action to
learn where they stand. In 1995, physicians reported initiating diet and drug
treatment at much lower cholesterol levels than in 1983, levels close to NCEP
recommendations. The CAS also shows that the NCEP guidelines for blood
cholesterol detection and treatment have become established practice. The
efforts of the NCEP and Coordinating Committee member organizations have led to
significant improvements in professional and public attitudes, knowledge, and
practices regarding high blood cholesterol and heart disease. Other indicators
show that the public's intake of saturated fat and total fat has declined; blood
cholesterol levels have dropped; and coronary heart disease (CHD) mortality has
continued to decline. Taken all together, the progress indicators demonstrate
that cholesterol education in the past decade has had a significant impact.
[Karl Note:
The American Heart Association, over a period of many
years, made false and misleading claims about the success
of their recommended methods of treating heart disease.
These claims have been repeated in thousands of places,
including official places, such as here in this Report.
The fact that the American Heart Association later
admitted that their claims were false, based in part on a
desire on their part to get more money for research, and
to demonstrate (even if it were false) that their efforts
were succeeding in reducing death rates from heart
disease. Since the AHA admitted their lies, the
thousands of other places, where the lie was repeated,
have, of course, NOT made any correction in their false
statements. So, you will find very "official" places,
like this REPORT, published by a government agency,
making the false claim that there has been "progress" in
the fight against heart disease, and that the programs
promoted by the Government have been good programs.
The deep and insidious nature of these lies pervades all
of society -- leading the great majority of people to
believe, falsely, that they should worry about lowering
their cholesterol levels. That is a worthless
objective. Karl Loren]
Return To Top
The NCEP Science Base
From its inception, the NCEP has based its
recommendations and messages firmly on sound scientific evidence. In January
1984, the Lipid Research Clinics Coronary Primary Prevention Trial provided the
long-sought, definitive evidence that lowering high blood cholesterol reduces
the risk of coronary heart disease. These results and a large body of evidence
from laboratory, epidemiologic, and clinical studies showed that not only are
high blood cholesterol levels an important risk factor for coronary heart
disease, but that these levels can be lowered safely by both diet and drugs.
The strength of the science base that has established the importance of
lowering high blood cholesterol to prevent CHD was underscored at an
NHLBI-sponsored science symposium in honor of the NCEP 10th anniversary, which
took place on December 4, 1995. Attended by almost 300 health professionals, the
symposium focused on recent scientific developments that have improved our
understanding of cholesterol's role in atherosclerosis and CHD.
The distinguished symposium speakers addressed important findings in
cholesterol research, including the explosion of new information resulting from
the application of cellular and molecular biology to the study of atherogenesis,
recent vascular biology research on the role of unstable plaque in triggering
heart attacks and other coronary "events," and the latest clinical trials. Among
the exciting developments covered at the symposium were the results of two
recent trials, 4S and West of Scotland, which provide conclusive evidence that
lowering blood cholesterol dramatically reduces heart attacks and CHD deaths as
well as overall death rates in patients with or without existing CHD.
Return To Top
The NCEP Program Areas
The scientific evidence supports a continuation
of NCEP's two-pronged strategy for reducing blood cholesterol levels:
- The high-risk or clinical approach, which promotes the detection and
treatment of individuals whose elevated blood cholesterol places them at
significantly increased risk for CHD;
- The population approach, which seeks to lower average levels of blood
cholesterol by encouraging reduced intakes of saturated fat, total fat, and
cholesterol by the general public.
The NCEP Partnership
In its decade of existence, the NCEP has relied on
partnerships to promote implementation of its strategies and guidelines. The
NCEP Coordinating Committee with its membership of more than 40 partner
organizations embodies this partnership principle. Through the Coordinating
Committee, the NCEP brings cholesterol information to a wide audience.
Consisting of representatives from major medical and health professional
associations, voluntary health organizations, community programs, and
governmental agencies, the Coordinating Committee is the NCEP's policy-setting
body and board of directors.
An important Coordinating Committee activity is sponsorship of expert panels
to develop guidelines for health professionals. The NCEP distributes the panels'
guidelines and recommendations to physicians and other health care professionals
and laboratories across the country. These panels include:
- Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (The Adult Treatment Panel)--developed guidelines for
detecting, evaluating, and treating high blood cholesterol in adults.
- Laboratory Standardization Panel--developed guidelines for
standardizing laboratory measurements and reporting of blood cholesterol
tests.
- Expert Panel on Population Strategies for Blood Cholesterol Reduction
(The Population Panel)--developed recommendations for reducing blood
cholesterol levels through populationwide adoption of eating patterns low in
saturated fat and cholesterol.
- Expert Panel on Blood Cholesterol Levels in Children and
Adolescents--developed recommendations for heart-healthy eating patterns for
children and adolescents, and for detecting and treating high blood cholesterol
in children and adolescents from high-risk families.
- Working Group on Lipoprotein Measurement--developed recommendations
on lipoprotein measurement discussing the measurement of LDL-cholesterol,
HDL-cholesterol, and triglycerides.
Member Organizations of the NCEP Coordinating Committee
[Karl Loren Note:
Here is the Hall of Infamy -- the shameful groups who
help spread lies!]
American Academy
of Family Physicians
American Academy of Pediatrics
American Association
of Occupational Health Nurses
American College of Cardiology
American
College of Chest Physicians
American College of Obstetricians and
Gynecologists
American College of Occupational Medicine
American College
of Preventive Medicine
American Diabetes Association, Inc.
American
Dietetic Association
American Heart Association
American Hospital
Association
American Medical Association
American Nurses'
Association
American Osteopathic Association
American Pharmaceutical
Association
American Public Health Association
American Red
Cross
Association of Black Cardiologists
Association of Life Insurance
Medical Directors of America
Association of State and Territorial Health
Officials
Citizens for Public Action on Blood Pressure and Cholesterol,
Inc.
National Black Nurses' Association, Inc.
National Heart, Lung, and
Blood Institute
National Medical Association
Society for Nutrition
Education
Associate Member Organizations of the NCEP Coordinating Committee
American Association of Office Nurses
American College of
Nutrition
Society for Public Health Education
Federal Agencies With Liaison Representatives to the NCEP Coordinating Committee
NHLBI Ad Hoc Committee on Minority Populations
Agency for
Health Care Policy and Research
Centers for Disease Control and
Prevention
Coordinating Committee for the Community Demonstration
Studies
Department of Agriculture
Department of Defense
Food and Drug
Administration
Health Resources and Services Administration
National
Cancer Institute
National Center for Health Statistics
Office of Disease
Prevention and Health Promotion
Department of Veterans Affairs
NCEP Goals and Objectives
The goal of the NCEP is to reduce the
prevalence of elevated blood cholesterol in the United States, and thereby
contribute to reducing coronary heart disease morbidity and mortality. To attain
this goal the NCEP has established the following objectives for health
professionals, patients and the public, and the community.
Objectives for Health Professionals
- To increase awareness among health professionals that elevated blood
cholesterol is a cause of coronary heart disease, and that reducing elevated
blood cholesterol levels will contribute to the reduction of coronary heart
disease risk.
- To improve the knowledge, attitudes, and skills of health professionals to
identify and intervene with patients who have elevated blood cholesterol, and to
provide guidelines regarding methods and approaches to use in detection,
treatment, and followup of patients.
- To encourage health professionals to consider an individual's blood
cholesterol level in relation to other CHD risk factors.
- To increase the awareness and understanding of health professionals
regarding the major role that diet plays in reducing elevated blood
cholesterol.
- To increase the awareness and understanding of health professionals
regarding the role of weight control and exercise in the management of high
blood cholesterol.
- To increase the knowledge of health professionals about the appropriate use
of cholesterol-lowering drugs.
- To increase the proportion of health professionals who diagnose and treat
patients with high blood cholesterol in accordance with the best existing
information (e.g., measuring blood cholesterol levels at appropriate intervals,
initiating treatment at appropriate levels of blood cholesterol, and providing
adequate counseling support to patients).
- To promote interdisciplinary collaborative efforts in the management of
patients with elevated blood cholesterol. Proper management of this condition
requires close cooperation among health professionals, including physicians,
nurses, dietitians, and pharmacists.
- To improve the knowledge, attitudes, and skills of students in the health
professions regarding high blood cholesterol and its management.
- To improve precision and accuracy in the measurement of blood cholesterol
levels and to promote standardized reporting of laboratory results.
Objectives for Patients and the Public
- To increase awareness that elevated blood cholesterol is a cause of coronary
heart disease, and that reducing elevated blood cholesterol levels will
contribute to the reduction of coronary heart disease risk.
- To increase the proportion of Americans who have reduced their dietary
intake of total fat, saturated fat, and cholesterol as part of a nutritionally
adequate diet.
- To increase the proportion of Americans who know their blood cholesterol
level.
- To encourage people identified as having high blood cholesterol to seek
professional advice and followup.
- To increase awareness that diet plays a major role in lowering high blood
cholesterol, that weight control and exercise also play a role in the management
of high blood cholesterol, and that, if necessary, drugs may be added to the
regimen.
- To increase public knowledge about the dietary principles for reducing blood
cholesterol levels.
- To increase the proportion of people with high blood cholesterol who adhere
to their cholesterol-lowering regimen.
Objectives for the Community
- To increase activities for blood cholesterol control at the State and
community level.
- To increase awareness and knowledge among students, especially those in
primary and secondary schools, with respect to blood cholesterol and
cardiovascular risk factors in general.
- To increase worksite activities to reduce elevated blood cholesterol levels.
- To develop program activities and products that are appropriate to the needs
of minorities and other special populations and to actively involve health
professionals and organizations that serve these populations.
- To promote increased dissemination of scientifically accurate
cholesterol-related information by print and electronic media.
Return To Top
For more information on the National Cholesterol Education Program, contact:
National Cholesterol Education Program
Information
Center
P.O. Box 30105
Bethesda, Maryland 20824-0105
(301)
251-1222
http://www.nhlbi.nih.gov/nhlbi/
Return To Top
The National Cholesterol Education Program (NCEP)
National Heart, Lung, and Blood Institute
Coordinating Committee Meeting
June 16, 1998
Omni Shorehan Hotel
Washington, D.C.
HIGHLIGHTS
- Dr. Michael Clearfield presented results from the Air Force/Texas Coronary
Atherosclerosis Prevention Study (AFCAPS/TexCAPS), a primary prevention trial,
which used lovastatin to lower cholesterol levels and found that cholesterol
lowering reduces the risk of coronary heart disease (CHD) events even in
patients without CHD who have relatively average serum cholesterol levels.
- Dr. Scott Grundy discussed incorporating triglycerides in the Adult
Treatment Panel (ATP) II approach. He suggested that the NCEP may want to place
increased emphasis on hypertriglyceridemia in ATP II and strengthen the
recommendations for weight reduction and increased physical activity.
[Karl Note:
Dr. Scott Grundy is one of the master planners, devising
a diet that exactly CAUSES heart disease. He is one
of the three terrible "trolls" I wrote about
HERE.]
Return To Top
- The American College of Nutrition and the Society for Public Health
Education were accorded full NCEP membership status in recognition of their
contributions to cholesterol education and the NCEP.
- Four guest speakers gave presentations on issues related to managed care.
After the presentations were delivered, the speakers formed a panel to answer
questions and enter into a discussion with Coordinating Committee members.
- Mr. Jeff Emerson, President and CEO of NYLCare, stated that health care
costs continue to rise, and in response, many employers have moved into managed
care. As a result, managed care organizations are focusing on quality of care
issues as a way to differentiate themselves to employers.
- Dr. Cheryl Warner, a clinical consultant with Harvard Pilgrim Health Care,
reported that Harvard Pilgrim Health Care and other health plans look to the
NCEP for science-based, nationally accepted guidelines that are easily
implemented.
- In a dialogue with Dr. Joseph Thompson, Vice President of the National
Committee for Quality Assurance (NCQA), Coordinating Committee members voiced
strong support for the implementation of a HEDIS cholesterol performance measure
that uses an LDL-cholesterol of less than or equal to 100 mg/dL as the treatment
goal for CHD patients. Coordinating Committee members criticized an NCQA
proposal for an LDL-cholesterol goal of less than or equal to 130 mg/dL as
having a variety of crucial scientific and health policy shortcomings.
Return To Top
- Dr. Jeffrey Kang, Director of the Office of Clinical Standards and Quality
of the Health Care Financing Administration (HCFA), reported that HCFA is
becoming more involved in managed care. HCFA uses performance measures to drive
quality improvement among health plans and providers, and to obtain information
about how to improve the health status of beneficiaries.
- Dr. Cleeman reported that several papers will be developed over the next 18
to 24 months to address issues and recommendations in ATP II that require
clarification or amplification. The following issues will be considered:
- Evaluation of triglyceride levels and integration of triglyceride management
with cholesterol-lowering treatment;
- Results of statin trials since the publication of ATP II in 1993, and the
implications of these studies for implementation of ATP II guidelines, including
initiation of drug treatment and treatment goals;
- Importance of dietary therapy, weight control, and exercise in lowering
blood cholesterol levels; and
[Karl Note:
Dr. Cleeman is one of the master planners, devising a
diet that exactly CAUSES heart disease. He is one
of the three terrible "trolls" I wrote about
HERE.]
Return To Top
- Overall CHD risk assessment and its relation to cholesterol reduction.
- The draft paper on cholesterol lowering in the elderly will be reviewed in
light of new evidence from recent studies and will be readied for submission to
a journal.
- A workshop to develop algorithms for predicting coronary risk in diverse
populations and identify policy questions about the application of such risk
assessment approaches is being planned by the NHLBI for January 1999.
- A continuing education packet containing the NCEP physician monograph
Cholesterol Lowering in the Patient With Coronary Heart Disease, the
accompanying patient booklet Live Healthier, Live Longer: Lowering
Cholesterol for the Person With Heart Disease, and a continuing medical
education self-assessment quiz was distributed to 200,000 physicians in late
1997 through the cooperative efforts of the University of Texas Southwestern
Medical Center and the NCEP.
- An interactive Web site that provides authoritative information to help CHD
patients reach their LDL-cholesterol goal (less than or equal to 100 mg/dL) will
be available by September 1, 1998, on the NHLBI Web site (www.nhlbi.nih.gov).
Return To Top
- Members were reminded that September is National Cholesterol Education
Month. Media activities will be held in conjunction with this month. Program
planners can obtain a kit of cholesterol-related educational materials through
the NHLBI Information Center and on the NHLBI Web site.
- The NHLBI Obesity Education Initiative's evidence-based clinical practice
guidelines will be formally presented at a press conference at the J.W. Marriott
Hotel in Washington, D.C., on June 17. The text of the guidelines will be
available on the NHLBI Web site (www.nhlbi.nih.gov).
Return To Top
- Members were divided into three small groups to facilitate more informative
discussions among Coordinating Committee members and guest speakers from the
managed care segment of the agenda. The chairpersons reported that the resulting
dialogue helped set the stage for increasing the understanding of how the NCEP
and the managed care industry can work together to promote the program's
messages and materials.
- Dr. Cleeman announced that members would receive the Healthy People 2010
objectives for review and comment. It is anticipated that the Healthy People
2010 report will be released for public comments between September 15 and
December 15, 1998.
Return To Top
- Dates for the next Coordinating Committee meetings are Tuesday, December 1,
1998, and Tuesday, October 12, 1999. Meetings are also scheduled for May and
December in the year 2000, but exact dates have not been determined.
Return To Top
National Heart, Lung, and Blood Institute
National Cholesterol Education Program
COORDINATING COMMITTEE MEMBERSHIP ROSTER
I. Representatives of Member Organizations
National Heart, Lung, and Blood Institute
Claude Lenfant, M.D.
(Chairman)[Karl
Note: Dr. Lenfant is one of the master planners,
devising a diet that exactly CAUSES heart disease.
He is one of the three terrible "trolls" I wrote about
HERE.]
Director
National Heart, Lung, and Blood Institute
National
Institutes of Health
Building 31, Room 5A52
31 Center Drive, MSC
2486
Bethesda, MD 20892-2486
Return To Top
James I. Cleeman, M.D.
Coordinator
National Cholesterol Education
Program
Office of Prevention, Education, and Control
National Heart, Lung,
and Blood Institute
National Institutes of Health
Building 31, Room
4A18
31 Center Drive, MSC 2480
Bethesda, MD 20892-2480
Theodore G. Ganiats, M.D.
University of California at San
Diego
Department of Family and Preventive Medicine
Ash Building, Room
103
9500 Gilman Drive
La Jolla, CA 92093-0622
Gary Graham, M.D.
Medical Director
International
Underwriting Services, Inc.
18-6 East Dundee Road
Barrington, IL 60010
Ronald
E. Kleinman, M.D.
Chief, Pediatric GI & Nutrition Unit
Massachusetts
General Hospital, Harvard Medical School
32 Fruit Street, VBK 107
Boston,
MA 02114
Anne Smith, R.N., C.O.H.N.-S.
Occupational Health
Consultant
450 East Conifer Lane
Clarksville, VA 23927
Richard
C. Pasternak, M.D., F.A.C.C.
Director, Preventive Cardiology and Cardiac
Rehabilitation
Massachusetts General Hospital
Jackson 1402
32 Fruit
Street
Boston, MA 02114
Gerald T. Gau, M.D.
Division of Internal Medicine and
Cardiovascular Diseases
Mayo Clinic
Floor W16B
200 First Street,
SW
Rochester, MN 55905
American College of Nutrition
Stanley
Wallach, M.D.
Executive Director
American College of Nutrition
Hospital
for Joint Diseases
301 East 17th Street
New York, NY 10003
Thomas E. Nolan, M.D.
Department of Obstetrics and
Gynecology
Louisiana State University Medical Center
1542 Tulane
Avenue
New Orleans, LA 70112-2825
Ruth Ann Jordan, M.D.
105 Rockwood
Street
Brookline, MA 02146
Lewis H. Kuller, M.D., Dr.P.H.
Professor and
Chairperson
Department of Epidemiology
University of
Pittsburgh
Graduate School of Public Health
130 DeSoto
Street
Pittsburgh, PA 15261
Alan J. Garber, M.D., Ph.D.
Professor of
Medicine
Biochemistry and Cell Biology
Baylor College of Medicine
Chief
of Endocrinology, Diabetes and Metabolism
The Methodist Hospital
Suite
1045
6550 Fannin
Houston, TX 77030
Linda Van Horn, Ph.D., R.D.
Professor of Preventive
Medicine
Northwestern University Medical School
Department of Preventive
Medicine
Room 1102
680 North Lake Shore Drive
Chicago, IL 60611-4402
Scott M. Grundy, M.D., Ph.D.
Director, Center for Human
Nutrition
Southwestern Medical Center at Dallas
Room Y3206
5323 Harry
Hines Boulevard
Dallas, TX 75235-9052
Sandra
Cornett, R.N., Ph.D.
Program Manager, Consumer Health Education
Department
of Consumer/Corporate Health and Wellness
Ohio State University Medical
Center
5th Floor Battelle
1375 Perry Street
Columbus, OH 43201
Yank
D. Coble, Jr., M.D.
2700 Riverside Avenue
Jacksonville, FL 32205
Joan E.
Watson, R.N., Ph.D., F.A.A.N.
Professor and Associate Dean
Research and
Graduate Education
School of Nursing
West Virginia University
6414
Health Sciences Center South
Morgantown, WV 2650
Michael Clearfield, D.O.
Professor and
Chairman
Department of Medicine
University of North Texas Health Science
Center
3500 Camp Bowie Boulevard
Fort Worth, TX 76107
James M. McKenney, Pharm.D.
Professor
Medical College
of Virginia
Virginia Commonwealth University
Box 533
MCV
Station
Richmond, VA 23298
Stephen Havas, M.D., M.P.H., M.S.
Associate
Professor
University of Maryland School of Medicine
Room 140
Howard
Hall
660 West Redwood Street
Baltimore, MD 21201
Vacant
Elizabeth Ofili, M.D.
Chief of Cardiology
Morehouse
School of Medicine
720 Westview Drive, S.W.
Atlanta, GA 30310
Joanne Mitten, M.H.E.
Chief
Bureau of Health
Promotion
Idaho Department of Health and Welfare
450 West State Street
P.O. Box 83720
Boise, ID 83720-0036
Citizens for Public Action on Blood Pressure and Cholesterol, Inc.
Gerald J. Wilson, M.A., M.B.A.
Executive Director
Citizens for
Public Action on Blood Pressure and Cholesterol, Inc.
Suite 101
10714
Kings Riding Way
Rockville, MD 20852
Linda Burnes-Bolton, Dr.P.H., R.N., M.S.N.,
F.A.A.N.
Vice President and Chief Nursing Officer
Cedars-Sinai Medical
Center
Room 2021
8700 Beverly Boulevard
Los Angeles, CA 90048
Luther
T. Clark, M.D.
Associate Professor of Clinical Medicine
Director of
Preventive Cardiology
State University of New York
Health Science Center
at Brooklyn
450 Clarkson Avenue
Box 1199
Brooklyn, NY 11203
Society for Nutrition Education
Darlene Lansing, M.P.H.,
R.D.
Nutrition Education Consultant
Lansing Squared, Inc.
2232
Wyndemere Lane
Eagen, MN 55122
Donald O. Fedder, Dr.P.H., M.P.H.
Professor
Department
of Pharmacy Practice and Science
University of Maryland School of
Pharmacy
Century Building, 2nd Floor
506 West Fayette Street
Baltimore,
MD 21201
II. Associate Member
Joyce Logan
Executive Director
American Association of
Office Nurses
109 Kinderkamack Road
Montvale, NJ 07645
III. Liaison Representatives
NHLBI Ad Hoc Committee on Minority Populations
Yvonne L. Bronner, Sc.D.,
R.D., L.D.
Assistant Professor
Department of Maternal and Child
Health
The Johns Hopkins University
School of Hygiene and Public
Health
624 North Broadway
Baltimore, MD 21205
Francis D. Chesley, M.D.
Medical Officer
Agency for
Health Care Policy and Research
Center for Practice and Technology
Assessment
Suite 310
6000 Executive Boulevard
Rockville, MD 20852
William H. Dietz, M.D., Ph.D.
Director
Division of
Nutrition and Physical Activity
National Center for Chronic Disease
Prevention and Health Promotion
Centers for Disease Control and
Prevention
4770 Buford Highway, N.E., MS K24
Atlanta, GA 30341-3714
Coordinating Committee for the Community Demonstration Studies
Thomas M.
Lasater, Ph.D.
Director
Division of Research
Brown University Center
for Primary Care and Prevention
Memorial Hospital of Rhode Island
111
Brewster Street
Pawtucket, RI 02860
Alanna
Moshfegh, M.S., R.D.
Research Leader
Agricultural Research
Service
Department of Agriculture
Unit 83
4700 River Road
Riverdale,
MD 20737
Col. Michael
D. Parkinson, M.D., M.P.H.
U.S. Air Force MC
HQ USAF/SGM
Room
400
110 Luke Avenue
Bolling Air Force Base
Washington, DC 20332-7050
Darla E.
Danford, Ph.D.
Director
Division of Science and Applied
Technology
Office of Special Nutritionals
Food and Drug
Administration
(MC HFS-465)
200 C Street, SW
Washington, DC 20204
Celia Hayes, M.P.H., R.D.
Senior Public Health
Analyst
Bureau of Health Resources Development
HIV/AIDS Bureau
Parklawn
Building, Room 7A-39
5600 Fishers Lane
Rockville, MD 20857
Carolyn
Clifford, Ph.D.
Chief, Diet and Cancer Branch
National Cancer
Institute
Executive Plaza North, Room 212
6130 Executive
Boulevard
Rockville, MD 20852
Clifford Johnson, M.P.H.
Acting Director
Division of
Health Examination Statistics
National Center for Health
Statistics
Centers for Disease Control and Prevention
Room 1000
6525
Belcrest Road
Hyattsville, MD 20782
Linda Meyers, Ph.D.
Acting Director
Office of
Disease Prevention and Health Promotion
Department of Health and Human
Services
200 Independence Avenue, S.W.
Humphrey Building, Room
738-G
Washington, DC 20201
Pamela Steele, M.D.
Program Chief for Cardiovascular
Diseases
Medical Services (111A)
VA Central Office
810 Vermont Avenue,
N.W.
Washington, DC 20420
Return To Top
-
Interactive Site: Lowering Cholesterol for
People with Heart Disease
- Cholesterol
Education Month Kit
- Stay
Young at Heart Recipes
- Facts About
Blood Cholesterol
- Check Your
Cholesterol and Heart Disease IQ
- Facts About Heart
Disease and Women: Reducing High Blood Cholesterol
- So You Have High Blood
Cholesterol
- Step-by-Step: Eating to
Lower Your High Blood Cholesterol
- Live
Healthier, Live Longer: Lowering Cholesterol for the Person With Heart
Disease
- Recommendations on
Lipoprotein Measurement
- Cholesterol Lowering
in the Patient With Coronary Heart Disease: Physician Monograph
- Cholesterol
Education Month Kit
- Second
Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (ATP II)
- Bibliography: Serum
Lipids in Blacks
- Recommendations
Regarding Public Screening for Measuring Blood Cholesterol
SUBSCRIBE:
The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.
You can view more than 50 back issues of this publication by clicking here.
The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.
It is automatically published on the Tuesday night just before the first Wednesday of every month.
You can subscribe to this free monthly electronic letter by entering your eMail address and name below.
You will then automatically receive a request for confirmation, sent to whatever address you have entered.
If you do NOT receive this confirmation request, then you will not be subscribed.
There may have been an error with your address and you should resubmit.
The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.
When you receive this confirmation request you must reply to it, or your subscription will not become active.
No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL:
You can remove yourself from the subscription list in several different ways.
Click here to read about this entire newsletter system.
Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.
If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.
Thus, no one else can unsubscribe you, from some other computer, without your knowledge.
But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message:
When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.
Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.
You can select particular information you would like to receive, along with the free cassette tape and catalog.
Click here to add the Wednesday Letter as a Channel on your desktop.
If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information).
Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month.
In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser.
You can turn on or off this channel, at will, and delete the channel from your desktop at any time.
With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.
You can reach Vibrant Life in many ways, including by mail to
Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.
Within the US and Canada, use
the toll free number: (800) 523-4521,
the local number: (818) 558-1799,
the FAX: (818) 558-7299,
eMail to kimberly@oralchelation.com
or any one of the hundreds of message forms throughout the 50 web sites.
Vibrant Life normally ships the same day we get an order.
There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.
Check out our companion site, at: http://www.oralchelation.net
where Karl's 2000 page book is published. Karl Loren is the author and
webmaster for this BOOK, as well as
for another web site about ORAL CHELATION.
His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:26 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.
Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:
One, that some form of copyright notice is included in every copy distributed or copied,
showing the copyright belonging to Vibrant Life, Burbank, CA, at
www.oralchelation.com .
The second condition is that the material is not to be used for any purpose contrary to
the purposes and objectives of this site.
This permission does not extend to materials on this site which are copyrighted by others.
